JESSICA FENNER: Open Payments
NPI 1003144882 · BARTONSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,269 in 69 payments from 12 companies in 2025. Trend: 2023 $478 · 2024 $1,059 · 2025 $1,269
Food & beverage: $1,269
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $241 |
| Madrigal Pharmaceuticals | 9 | $185 |
| ABBVIE INC. | 10 | $162 |
| Janssen Biotech, Inc. | 9 | $158 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $146 |
| Aimmune Therapeutics, Inc. | 5 | $103 |
| Novo Nordisk Inc | 4 | $91 |
| Phathom Pharmaceuticals, Inc. | 3 | $59 |
| PFIZER INC. | 3 | $55 |
| Ardelyx, Inc. | 1 | $28 |
Products named: REZDIFFRA, ENTYVIO, TREMFYA, XIFAXAN, ZENPEP, Wegovy, EOHILIA, VOQUEZNA.
Industry payments across PA — which companies pay providers there.
